MoneyWorks4Me

Gland Pharma - Quaterly Results

06 Aug 2024 Evaluate
The revenue zoomed 14.47% to Rs. 10120.24 millions for the quarter ended June 2024 as compared to Rs. 8840.70 millions during the corresponding quarter last year.The Company has registered profit of Rs. 2229.21  millions for the quarter ended June 2024, a growth of 18.84%  over Rs. 1875.82 millions millions achieved in the corresponding quarter of last year.Operating Profit saw a handsome growth to 3420.43 millions from 2945.69 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 10120.24 8840.70 14.47 10120.24 8840.70 14.47 41674.28 36165.28 15.23
Other Income 484.90 352.07 37.73 484.90 352.07 37.73 1666.66 2404.64 -30.69
PBIDT 3420.43 2945.69 16.12 3420.43 2945.69 16.12 15754.47 12590.13 25.13
Interest 9.11 15.96 -42.92 9.11 15.96 -42.92 78.43 74.14 5.79
PBDT 3411.32 2929.73 16.44 3411.32 2929.73 16.44 15676.04 11951.38 31.17
Depreciation 408.17 389.82 4.71 408.17 389.82 4.71 1621.07 1467.36 10.48
PBT 3003.15 2539.91 18.24 3003.15 2539.91 18.24 14054.97 10484.02 34.06
TAX 773.94 664.09 16.54 773.94 664.09 16.54 3621.72 2725.76 32.87
Deferred Tax 11.82 75.29 -84.30 11.82 75.29 -84.30 246.84 -27.99 -981.89
PAT 2229.21 1875.82 18.84 2229.21 1875.82 18.84 10433.25 7758.26 34.48
Equity 164.75 164.70 0.03 164.75 164.70 0.03 164.71 164.70 0.01
PBIDTM(%) 33.80 33.32 1.44 33.80 33.32 1.44 37.80 34.81 8.59
Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..